ORAL ANTICOAGULANTS - TOTEM AND TABOO

被引:8
作者
BRECKENRIDGE, A [1 ]
机构
[1] UNIV LIVERPOOL, LIVERPOOL L69 3BX, ENGLAND
来源
BMJ-BRITISH MEDICAL JOURNAL | 1976年 / 1卷 / 6007期
关键词
D O I
10.1136/bmj.1.6007.419
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:419 / 423
页数:5
相关论文
共 60 条
[1]  
BARRITT DW, 1960, LANCET, V1, P1309
[2]   WARFARIN AND INHIBITION OF VITAMIN-K ACTIVITY BY AN OXIDE METABOLITE [J].
BELL, RG ;
MATSCHINER, JT .
NATURE, 1972, 237 (5349) :32-+
[3]  
BRADFORDHILL A, 1962, STATISTICAL METHODS
[4]   PLASMA HALF-LIVES AND PHARMACOLOGICAL EFFECT OF ENANTIOMERS OF WARFARIN IN RATS [J].
BRECKENRIDGE, A ;
LEORME, M .
LIFE SCIENCES PT-2 BIOCHEMISTRY GENERAL AND MOLECULAR BIOLOGY, 1972, 11 (07) :337-+
[5]   DRUG INTERACTIONS WITH WARFARIN - STUDIES WITH DICHLORALPHENAZONE, CHLORAL HYDRATE AND PHENAZONE (ANTIPYRINE) [J].
BRECKENRIDGE, A ;
ORME, ML ;
THORGEIRSSON, S ;
DAVIES, DS ;
BROOKS, RV .
CLINICAL SCIENCE, 1971, 40 (04) :351-+
[6]  
BRECKENRIDGE A, 1974, DRUG INTERACTIONS, P223
[7]  
BRECKENRIDGE A, 1973, BIOL EFFECTS DRUGS R, P145
[8]  
BRECKENRIDGE A, 1969, CLINICAL PHARMACOLOG, V10, P22
[9]  
BRODIE BB, 1964, PHARMACOLOGIST, V6, P12
[10]  
BUTT H. R., 1941, PROC STAFF MEET MAYO CLINIC, V16, P388